Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585779 · ClinicalTrials.gov registry record
Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial
A clinical trial, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- 64
- Enrollment target
NCT01585779: Completed study, sponsored by Medtronic Cardiovascular.
NCT01585779 is a clinical trial that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 64 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585779 has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
Study Summary
The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
Primary Outcome
The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment. Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant.
Interventions
- DEVICE Contour 3D® implant for tricuspid valve repair
- DEVICE Tri-Ad® implant for tricuspid valve repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-06 |
What the finished NCT01585779 record still lists
NCT01585779 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Contour 3D® implant for tricuspid valve repair is the first listed.
NCT01585779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01585779 about?
NCT01585779 is a clinical study titled "Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial". The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
What is the current status of trial NCT01585779?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2012-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01585779?
The interventions under investigation include: Contour 3D® implant for tricuspid valve repair (DEVICE), Tri-Ad® implant for tricuspid valve repair (DEVICE).
Who is sponsoring clinical trial NCT01585779?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia